Pharmaceutical Advertising

Pharmaceutical advertising covers promotional communications from drug manufacturers to patients and healthcare providers, including broadcast spots, digital ads, and social media campaigns. In AI governance coverage, the tag captures stories about companies using generative AI to produce or target this content, which raises questions about accuracy, required risk disclosures, and substantiation of claims. For compliance and legal teams, these stories signal where regulators such as the US Food and Drug Administration may apply existing advertising rules to AI-generated material.

1 item

Corporate PolicyUS2026-10-22

Ad-Funded Clinical AI Used by 64% of US Physicians Raises Accuracy and Oversight Gaps

OpenEvidence, a Miami-based AI medical search platform valued at $15 billion, is now used by roughly two-thirds of US physicians. The platform is funded by pharmaceutical advertising and has withdrawn from the EU and UK citing the EU AI Act. Independent research found it underperformed general-purpose AI models on clinical benchmarks.

OpenEvidence clinical AI healthcare AI risk conflict of interest EU AI Act human oversight pharmaceutical advertising